InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Smith Geoffrey Wade. Director active across 1 company, notably Orchestra BioMed Holdings, Inc.. Aggregated, 3 reports have been recorded. History available since 20 July 2023. The latest transaction was filed on 20 July 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条